43 related articles for article (PubMed ID: 28410294)
1. Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India.
Bajpai J; Munot P; Kota K; Gupta G; Gala K; Gulia A; Rekhi B; Khanna N; Shetty N; Bhargava P; Srinivas S; Ostwal V; Patil V; Noronha V; Kulkarni S; Laskar S; Prabhash K; Chinnaswamy G; Gupta S; Banavali S
JCO Glob Oncol; 2024 May; 10():e2300308. PubMed ID: 38723218
[TBL] [Abstract][Full Text] [Related]
2. Building the Evidence for Systemic Treatment in Desmoid Fibromatosis: Is a New Metronomic Regimen Another Layer in the Foundation?
Alcindor T
JCO Glob Oncol; 2024 May; 10():e2300488. PubMed ID: 38723215
[TBL] [Abstract][Full Text] [Related]
3. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy.
Caglar K; Ozyönüm H; Akalin M; Balci S
Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
[TBL] [Abstract][Full Text] [Related]
6. Therapy of desmoid tumors and fibromatosis using vinorelbine.
Weiss AJ; Horowitz S; Lackman RD
Am J Clin Oncol; 1999 Apr; 22(2):193-5. PubMed ID: 10199460
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis.
Park KH; Choi YJ; Kim KW; Ro KH; Kang CH; Song SH; Park JH
Jpn J Clin Oncol; 2016 Sep; 46(9):845-9. PubMed ID: 27365524
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate and Vinblastine or Vinorelbine Remain Useful Treatments for Desmoid-Type Fibromatosis 30 Years Later.
Schuetze SM
Cancer J; 2017; 23(2):92-94. PubMed ID: 28410294
[No Abstract] [Full Text] [Related]
9. Aggressive fibromatosis of the neck treated with a combination of chemotherapy and indomethacin.
Longhi A; Errani C; Battaglia M; Alberghini M; Ferrari S; Mercuri M; Molinari M
Ear Nose Throat J; 2011 Jun; 90(6):E11-5. PubMed ID: 21674455
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.
Tsukamoto S; Takahama T; Mavrogenis AF; Tanaka Y; Tanaka Y; Errani C
Musculoskelet Surg; 2023 Mar; 107(1):7-18. PubMed ID: 35150408
[TBL] [Abstract][Full Text] [Related]
11. Desmoid tumors: who, when and how to treat?
Mikhael R; Smith M; Tzanis D; Watson S; Miah AB; Bonvalot S
Curr Opin Oncol; 2022 Jul; 34(4):335-341. PubMed ID: 35837705
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]